INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.48 Cr | ₹1.22 Cr | ₹6.29 Cr | ₹2.41 Cr | ₹1.46 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.48 Cr |
| Mar2024 | ₹1.22 Cr |
| Mar2023 | ₹6.29 Cr |
| Mar2022 | ₹2.41 Cr |
| Mar2021 | ₹1.46 Cr |
How is Cash Flow from Financing Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.48 Cr | Negative | |
| Mar2024 | ₹1.22 Cr | -80.68 | |
| Mar2023 | ₹6.29 Cr | 160.95 | |
| Mar2022 | ₹2.41 Cr | 64.96 | |
| Mar2021 | ₹1.46 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹154.9 Cr | -0.7% | -10.6% | -44.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,585.3 Cr | -2.6% | -9.4% | -38.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,317.7 Cr | -7.9% | 9.5% | 11.1% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,309.5 Cr | -4.4% | -1.3% | 11.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹939.2 Cr | -0.6% | 2.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹513.5 Cr | -2.3% | 4.2% | 3.1% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.7% |
-10.6% |
-44.8% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses